Management of suspected or confirmed exposure to hepatitis B virus

National HBV Testing Policy Expert Reference Committee 2020

The general principles of postexposure prophylaxis (PEP) against hepatitis B virus are summarised in Management of adults with suspected or confirmed exposure to hepatitis B virus.

Table 1. Management of adults with suspected or confirmed exposure to hepatitis B virus

Exposed person is immune [NB1]

Exposed person is not immune [NB1]

Source is HBsAg negative and unlikely to be in window period [NB2]

No further follow-up testing required.

No preventive measures required.

No further follow-up testing required.

Start a course of hepatitis B vaccination as soon as possible, preferably within 24 hours of exposure [NB3].

Source is HBsAg positive

No further follow-up testing required.

No preventive measures required.

Test the exposed person for HBsAg at baseline, 3 months and 6 months after the exposure.

Start a course of hepatitis B vaccination as soon as possible, preferably within 24 hours of exposure [NB3].

Administer hepatitis B immunoglobulin within 72 hours of exposure [NB3] [NB4].

Source HBsAg status is unknown and cannot be urgently determined

No further follow-up testing required.

No preventive measures required.

Test the exposed person for HBsAg at baseline, 3 months and 6 months after the exposure.

Start a course of hepatitis B vaccination as soon as possible, preferably within 24 hours of exposure [NB3].

If occupationally exposed to the blood of unidentified people, administer hepatitis B immunoglobulin within 72 hours of exposure [NB3].

Note:

HBsAg = hepatitis B surface antigen

NB1: A person is immune if they have evidence of seroconversion after hepatitis B vaccination, or natural immunity from past infection.

NB2: The window period refers to the time between infection and when hepatitis B virus is detectable.

NB3: For immunisation and immunoglobulin dosing and schedule recommendations, see the Australian Immunisation Handbook.

NB4: In the case of sexual exposure, hepatitis B immunoglobulin may be given up to 14 days after the last exposure.